Analysts Issue Forecasts for Spectral AI Q1 Earnings

Key Points

• HC Wainwright forecasts that Spectral AI will post earnings per share of ($0.12) for Q1 2026, with a full-year estimate of ($0.48).
• Recent analysis from Wall Street Zen upgraded Spectral AI from a "sell" rating to a "hold" rating.
• Spectral AI stock has seen a slight decline of 0.5%, with recent trading at $2.09, while the company has a market cap of approximately $52.92 million.

Spectral AI, Inc. (NASDAQ:MDAI - Free Report) - Stock analysts at HC Wainwright issued their Q1 2026 earnings per share (EPS) estimates for Spectral AI in a report issued on Thursday, August 14th. HC Wainwright analyst S. Ramakanth anticipates that the company will post earnings of ($0.12) per share for the quarter. The consensus estimate for Spectral AI's current full-year earnings is ($0.48) per share. HC Wainwright also issued estimates for Spectral AI's Q2 2026 earnings at $0.10 EPS, Q3 2026 earnings at $0.12 EPS and Q4 2026 earnings at $0.12 EPS.

Separately, Wall Street Zen cut Spectral AI from a "hold" rating to a "strong sell" rating in a research report on Saturday.

Spectral AI Stock Up 0.2%

Shares of NASDAQ:MDAI traded up $0.01 on Friday, reaching $2.13. The company had a trading volume of 20,950 shares, compared to its average volume of 535,073. Spectral AI has a twelve month low of $0.82 and a twelve month high of $3.25. The stock has a 50-day moving average price of $2.42 and a 200 day moving average price of $1.83. The stock has a market capitalization of $53.80 million, a P/E ratio of -3.09 and a beta of 0.90.

Spectral AI (NASDAQ:MDAI - Get Free Report) last announced its quarterly earnings results on Tuesday, August 12th. The company reported ($0.10) earnings per share for the quarter, missing analysts' consensus estimates of ($0.07) by ($0.03). The business had revenue of $5.07 million during the quarter, compared to the consensus estimate of $5.44 million.

Hedge Funds Weigh In On Spectral AI

Institutional investors have recently made changes to their positions in the business. Northern Trust Corp bought a new position in shares of Spectral AI in the fourth quarter worth about $44,000. Jane Street Group LLC bought a new position in shares of Spectral AI in the second quarter worth about $74,000. Marshall Wace LLP bought a new position in shares of Spectral AI in the second quarter worth about $104,000. DNB Asset Management AS bought a new position in shares of Spectral AI in the second quarter worth about $107,000. Finally, XTX Topco Ltd bought a new position in shares of Spectral AI in the second quarter worth about $123,000. 67.08% of the stock is currently owned by institutional investors.

About Spectral AI

Spectral AI, Inc, an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers.